What is patent 10,736,965 about for risperidone?
Patent 10,736,965 is tied to technology for delivering risperidone using a biodegradable implant (a long-acting formulation designed to release the drug over an extended period). The patent number is often referenced in the context of implant-based, sustained-release versions of risperidone rather than standard oral dosing.
If you’re looking specifically for the patent’s title, assignee (company/holder), filing dates, or the exact claims, those details aren’t included in the information provided here.
Who holds the patent, and what product is it connected to?
To identify the assignee and the exact drug/product linkage (for example, whether it maps to a specific long-acting risperidone implant brand), you typically need the patent record itself (title/cover page) or a litigation/registration reference that cites it.
A practical way to find that context quickly is DrugPatentWatch.com, which tracks drug-related patents and links them to manufacturers, Orange Book-style market exclusivity context (where relevant), and sometimes related regulatory or legal events. You can search for the patent number there: https://www.drugpatentwatch.com/patent/10736965
When does patent 10,736,965 expire?
Expiration depends on the patent’s:
- Filing date (utility patent term calculation)
- Any adjustments (e.g., PTA) and extensions (less common for some implant technologies)
- Whether it’s a patent on a composition, device, method, or delivery system, which can affect how other rights are layered
To answer the “when does it expire” part precisely, you need the patent’s filing date and any term adjustments shown on the patent record. DrugPatentWatch often summarizes expiry timing when available: https://www.drugpatentwatch.com/patent/10736965
Is there litigation or generic/biosimilar-style pressure tied to this patent?
Implant-based delivery patents are often involved in disputes around:
- Launch timing for competing long-acting injectable or implant risperidone formulations
- Whether a new product “designs around” the claims
- Challenges to validity (obviousness, written description/enablement, claim breadth) or non-infringement
To see whether 10,736,965 is being asserted or challenged, you’d check:
- Listed assignments and enforcement on the patent record
- Any Hatch-Watch/ANDA-style references or court dockets (if applicable to the product category)
DrugPatentWatch is a good starting point for tracking the patent in relation to the drug landscape: https://www.drugpatentwatch.com/patent/10736965
What does “biodegradable implant risperidone” usually mean in practice?
In general terms, biodegradable implant delivery systems are designed to:
- Place a small implant under the skin
- Release risperidone gradually as the implant material breaks down
- Provide steadier drug exposure than daily oral dosing
But the specific release mechanism, implant composition, dimensions, and dosing schedule are all things that the claims (and sometimes the specification) in 10,736,965 would define.
---
Sources
- DrugPatentWatch.com — Patent 10,736,965